关注
Fatima Alduraibi
Fatima Alduraibi
KFSH&RC, UAB, BIDMC
在 bidmc.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Prevalence of HLA-B27 in the general population and in patients with axial spondyloarthritis in Saudi Arabia
MA Omair, FK AlDuraibi, MK Bedaiwi, S Abdulaziz, W Husain, ...
Clinical Rheumatology 36, 1537-1543, 2017
252017
Lupus nephritis correlates with B cell interferon-β, anti-Smith, and anti-DNA: a retrospective study
F Alduraibi, H Fatima, JA Hamilton, WW Chatham, HC Hsu, JD Mountz
Arthritis Research & Therapy 24 (1), 87, 2022
142022
Host genetics but not commensal microbiota determines the initial development of systemic autoimmune disease in BXD2 mice
H Hong, F Alduraibi, D Ponder, WL Duck, CD Morrow, JB Foote, ...
Arthritis & Rheumatology 74 (4), 634-640, 2022
122022
Mycobacterium tuberculosis in solid organ transplantation: incidence before and after expanded isoniazid prophylaxis
SM Al-Mukhaini, H Al-Eid, F Alduraibi, HI Hakami, H Al Talhi, M Shoukri, ...
Annals of Saudi Medicine 37 (2), 138, 2017
122017
Clustering patients with gout based on comorbidities and biomarkers: a cross-sectional study
FK Alduraibi, M Saleem, K Ricart, RP Patel, AJ Szalai, JA Singh
The Journal of Rheumatology 50 (6), 817-826, 2023
102023
Lupus nephritis biomarkers: a critical review
FK Alduraibi, GC Tsokos
International Journal of Molecular Sciences 25 (2), 805, 2024
82024
IL-4 receptor blockade is a global repressor of naïve B cell development and responses in a dupilumab-treated patient
JD Mountz, M Gao, DM Ponder, S Liu, CW Sun, F Alduraibi, K Sullivan, ...
Clinical Immunology, 2022
82022
Interrelation of T cell cytokines and autoantibodies in systemic lupus erythematosus: A cross-sectional study
FK Alduraibi, KA Sullivan, WW Chatham, HC Hsu, JD Mountz
Clinical Immunology 247, 109239, 2023
72023
How to Use Janus Kinase Inhibitors in the Treatment of Rheumatoid Arthritis? A Clinical Assessment of Risks and Benefits
FK Alduraibi, JA Singh
Current Rheumatology Reports 25 (12), 295-306, 2023
2023
Increased development of T-bet+ CD11c+ B cells predisposes to lupus in females: Analysis in BXD2 mouse and genetic crosses
KA Sullivan, C Chapman, L Lu, DG Ashbrook, Y Wang, FK Alduraibi, C Lu, ...
Clinical Immunology 257, 109842, 2023
2023
Thank you to the reviewers of Rheumatology
M Bukhari
Rheumatology 62 (8), 2639-2645, 2023
2023
Interrelation of T-cell Cytokines and Autoantibodies in Lupus Nephritis: A Cross-sectional Study
F Alduraibi, K Sullivan, WW Chatham, HC Hsu, JD Mountz
2022
Distinct Clinical Manifestations Associated with Autoantibodies and Cytokines in Systemic Lupus Erythematosus
F Alduraibi
ProQuest Dissertations & Theses Global, 2022
2022
2022 Western Medical Research Conference
E Batton, S Laies, K Vo, S Bukhari, C Fateri, A Freifeld, D Mesa
J Investig Med 70, 110-345, 2022
2022
Clustering Patients with Gout Based on Comorbidities and Biomarkers: A Cross-Sectional Study
F Alduraibi, R Saleem, Mohammad, P Karina, S Rakesh, S Alexander, ...
The 13th European Crystal Workshop, https://www.european-crystal-network.com, 2022
2022
B-CELL INTERFERON-b CORRELATES WITH LUPUS NEPHRITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
FK Alduraibi, H Fatima, W Chatham, H Hsu, J Mountz
JOURNAL OF INVESTIGATIVE MEDICINE 70 (1), 321-321, 2022
2022
510 B-cell interferon-β correlates with lupus nephritis in systemic lupus erythematosus
F Alduraibi, H Fatima, JA Hamilton, WW Chatham, HC Hsu, JD Mountz
Lupus Science & Medicine 8 (Suppl 2), 2021
2021
Role of B-cell endogenous interferon beta in lupus nephritis
FK Alduraibi, HC Hsu, H Fatima, WW Chatham, JD Mountz
The Journal of Immunology 206 (1_Supplement), 52.13-52.13, 2021
2021
B Cell Intracellular IFNβ as a Unique Cellular Marker for the Development of Lupus Nephritis
F Alduraibi, H Fatima, W Chatham, HC Hsu, J Mountz
ARTHRITIS & RHEUMATOLOGY, 2021
2021
Endogenous Interferon-beta and Low IL-4R on Transitional B Cells Promotes Lupus Nephritis
F Alduraibi, H Fatima, WW Chatham, HC Hsu, J Mountz
ARTHRITIS & RHEUMATOLOGY 72, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–20